Displaying items by tag: careless talk

In January the AstraZeneca vaccine was approved in Europe for all adults. But several countries, including France and Germany, restricted its use in over-65s due to a lack of data about its effectiveness. France’s Emmanuel Macron claimed the vaccine was ‘quasi-ineffective’ in older age groups, and the German newspaper Handelsblatt had a similar report; but these statements are unfounded. In the over-80s, a single shot of either the AstraZeneca or Pfizer vaccine appears to be over 80% effective at preventing hospitalisation. Although the regulators have both now reversed their advice, the majority of their AstraZeneca doses are yet to be used. It seems that the regulators’ prevarications, and loose talk from politicians and bureaucrats, have undermined confidence in the AstraZeneca vaccine.